Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Acta Med Croatica ; 70(4-5): 309-14, 2016 12.
Artigo em Servo-Croata (Latino) | MEDLINE | ID: mdl-29087164

RESUMO

Renal tissue is sensitive to the effect of potentially nephrotoxic drugs and other substances that are available over-the-counter or can be purchased at healthy food stores or elsewhere, and harmful substances from the environment. The harmful effects of these substances lead to the development of recognizable clinical syndromes, including acute or chronic renal failure, tubulopathy, and proteinuria. Risk factors that influence the development of kidney disease induced by drugs are divided into those related to patient characteristics, drug characteristics, and renal function. Drugs that commonly exhibit nephrotoxic effects are analgesics, antimicrobials, chemotherapeutics, contrast agents, immunosuppressants, herbal preparations and substances containing heavy metals. Family physician must carefully observe their patients, nurturing individual approach to drug selection and determining the dose. Renal function can quickly return to normal if the damage is recognized on time. Recent research yields insights into the identification of new biomarkers that will contribute to early detection of drug induced kidney damage.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Substâncias Protetoras/administração & dosagem , Insuficiência Renal Crônica/etiologia , Insuficiência Renal Crônica/prevenção & controle , Injúria Renal Aguda/etiologia , Analgésicos/efeitos adversos , Analgésicos não Narcóticos/efeitos adversos , Biomarcadores/sangue , Meios de Contraste/efeitos adversos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Insuficiência Renal Crônica/sangue
2.
Acta Med Croatica ; 69(4): 271-8, 2015 11.
Artigo em Servo-Croata (Latino) | MEDLINE | ID: mdl-29083837

RESUMO

Dyspepsia is a common symptom among patients in family medicine practice. The prevalence in adult population is about 40%. Two-thirds of patients have functional dyspepsia. Clinical assessment, diagnostic procedures and treatment of patients depend on the age, symptoms and Helicobacter pylori infection. In patients with dyspepsia, it is necessary to assess the potential impact of other concurrent diseases and medications that the patient regularly uses. Prompt or early endoscopy is recommended in patients with newly detected dyspepsia older than 50 and presenting with alarming symptoms. In persons younger than 50, the recommended strategy is 'test and treat'. In some patients, treatment is carried out by acid suppression. In patients failing to achieve success in treatment, further endoscopic diagnosis is indicated. Ultrasound diagnostics in primary care can significantly contribute to diagnostic evaluation and early treatment in patients with hepatobiliary and pancreas diseases presenting with symptoms of dyspepsia. Treatment of concurrent mental disorders can improve the symptoms of dyspepsia. Treatment of patients who do not respond to the recommended treatment strategies is a challenge for family physicians. Regular visits and psychotherapeutic support in these patients can reduce the level of anxiety and encourage the patient for treatment of psychological morbidity, as well as his efforts in healthy behavior.


Assuntos
Dispepsia/diagnóstico , Dispepsia/terapia , Medicina de Família e Comunidade/métodos , Relações Médico-Paciente , Adulto , Antibacterianos/uso terapêutico , Fármacos Gastrointestinais/uso terapêutico , Educação em Saúde/métodos , Humanos
3.
Acta Med Croatica ; 69(4): 287-91, 2015 11.
Artigo em Servo-Croata (Latino) | MEDLINE | ID: mdl-29083839

RESUMO

Peptic ulcer disease is represented by a lesion in the mucosa of the digestive tract due to imbalance of its aggressive and protective mechanisms. The main external factors of the development of peptic ulcers are Helicobacter pylori infection and the use of non-steroidal anti inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA). Symptoms of peptic ulcer disease are a common reason for visiting the family physician. All patients with symptoms of dyspepsia under the age of 50 and without the alarm symptoms should be tested whether H. pylori is present by performing the Urea Breath Test or stool antigene testing, and infection, if found, should be treated. Endoscopic examination is obligatory in patients older than 50 years and those with alarm symptoms. "Sequential therapy" is recommended in Croatia as the first-line treatment of H. pylori infection, or triple therapy that comprises applying a proton pump inhibitor (PPI) in combination with amoxicillin and metronidazole. Four weeks after eradication therapy the control testing for H. pylori should be performed.


Assuntos
Antiulcerosos/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Úlcera Péptica/tratamento farmacológico , Úlcera Péptica/etiologia , Antibacterianos/uso terapêutico , Anti-Inflamatórios não Esteroides , Quimioterapia Combinada , Feminino , Infecções por Helicobacter/complicações , Helicobacter pylori , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA